Brief: Ginkgo Bioworks Integrates Callisto For Difficult-To-Automate Ngs Processes In Their High-Throughput Lab
21/02/2025 14:02
Feb 21 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :
* GINKGO BIOWORKS INTEGRATES CALLISTO FOR
DIFFICULT-TO-AUTOMATE
NGS PROCESSES IN THEIR HIGH-THROUGHPUT LAB
Source text: ID:nPn9TgCJJa
Further company coverage: DNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary